ScottishPower has announced a £4 million commitment to Cancer Research UK’s (CRUK) Lung Cancer Centre of Excellence (LCCE) as part of its ongoing partnership with the national charity. The funding aims to bolster groundbreaking lung cancer research, one of the UK’s most common and deadliest forms of cancer.
This latest pledge is part of ScottishPower’s wider goal to raise £10 million by 2029, building on the £40 million already raised since the partnership began in 2012. The funding will enhance research into lung cancer, supporting CRUK’s mission to create a world where people live longer, healthier lives, free from the fear of cancer.
Transforming Lung Cancer Research
The LCCE unites world-leading researchers to develop cutting-edge treatments for lung cancer. With the new funding, CRUK aims to build a sustainably funded research community, advance treatments, and explore prevention and early detection methods for this hard-to-treat disease.
Michelle Mitchell, CEO of Cancer Research UK, praised the partnership:
“We’re thrilled ScottishPower will support the CRUK Lung Cancer Centre of Excellence and the broad work of the charity. Over the past decade, the Centre has advanced treatment for lung cancer. With ScottishPower’s support, we can sustain momentum and enhance research infrastructure to discover new methods for preventing, detecting, and treating lung cancer.”
ScottishPower’s Long-Standing Commitment
ScottishPower CEO Andrew Ward expressed pride in the partnership:
“Cancer affects all of us, whether personally or through someone we care for. Lung cancer is one of the UK’s biggest killers, and it’s incredibly important to me that this money goes where it’s needed most—helping with research to ultimately help more people live longer, better lives, free from the fear of cancer.
Since 2012, ScottishPower has raised funds through initiatives such as the Help Beat Cancer energy tariff, employee and customer fundraising, and sponsorship of CRUK’s Race for Life and Stand Up to Cancer campaigns.
Advancing Research on Air Pollution and Cancer
The funding builds on ScottishPower’s previous support for CRUK’s studies into the links between air pollution and lung cancer. During COP26 in Glasgow, the company funded the TOPICAL study, led by CRUK’s Chief Clinician and LCCE Co-Director, to explore how air pollution contributes to lung cancer, particularly in non-smokers.
The study’s findings are now shaping innovative approaches to diagnosing and treating lung cancer, contributing to a broader understanding of environmental factors in cancer development.
A Vision for the Future
ScottishPower’s partnership has supported CRUK’s pioneering work by backing over 4,000 UK scientists, doctors, and nurses. This latest commitment reflects its ongoing dedication to tackling cancer through research, prevention, and community support.
With a shared vision of a cancer-free future, the partnership continues to inspire hope and drive meaningful progress in the fight against one of the world’s most challenging diseases.
More news from Glasgow
